The long-term goals of the Cancer Genetics and Epigenetics (CGE) Program are to understand the genetic and epigenetic mechanisms responsible for cancer development and to translate this knowledge into better therapeutic strategies and outcomes. CGE is one of the two basic science Programs of the Herbert Irving Comprehensive Cancer Center (HICCC). Two significant changes took place since the last review in 2008: 1) Dr. Gautier assumed the leadership of the CGE Program and 2) the Program was reorganized around the two themes of I) Genome Plasticity and II) Epigenetics. Previous members of the original Cell Division theme of CGE have now been integrated into the remaining themes or moved to the newly-formed Tumor Microenvironment theme of the Cancer Regulatory Networks (CRN) Program. The CGE Program promotes and facilitates interactions among its members (intra-programmatic interactions) and with other HICCC members in its other Programs (inter-programmatic interactions), as well as with cancer scientists at other NCI-supported Cancer Centers nationwide (inter-cancer center interactions). The Program provides a forum in which CGE investigators share their latest discoveries and seek translational applications of their work. The Program also stimulates research by providing investigator feedback to the HICCC Senior Leadership Team (SLT) and the HICCC Shared Resources (SRs). Finally, the CGE Program employs multiple Cancer Center-wide and Program-specific mechanisms to encourage clinical application of basic science discoveries. Recent translation of basic research findings from CGE include the development of new methodologies for genome data mining, the identification of new cancer-causative genetic lesions, screening and development of small molecules altering DNA repair and responses to cancer chemotherapeutics, and genetic screens to uncover cancer-specific weaknesses - or addictions - as tailored therapeutic targets. The CGE Program consists of 26 members and 5 clinical members from 14 Columbia University Departments in the School of Art and Sciences, the School of Public Health and the College of Physicians & Surgeons. The Program hosts several collaborative efforts, including an NCI-funded Program Project Grant entitled

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-40
Application #
8753110
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-07-04
Project End
2019-06-30
Budget Start
2014-07-17
Budget End
2015-06-30
Support Year
40
Fiscal Year
2014
Total Cost
$33,319
Indirect Cost
$12,495
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Jauregui, Ruben; Thomas, Amanda L; Liechty, Benjamin et al. (2018) SCAPER-associated nonsyndromic autosomal recessive retinitis pigmentosa. Am J Med Genet A :
Ghorpade, Devram S; Ozcan, Lale; Zheng, Ze et al. (2018) Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature 555:673-677
Bianchetti, E; Bates, S J; Carroll, S L et al. (2018) Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors. Sci Rep 8:17390
Jauregui, Ruben; Park, Karen Sophia; Duong, Jimmy K et al. (2018) Quantitative Comparison of Near-infrared Versus Short-wave Autofluorescence Imaging in Monitoring Progression of Retinitis Pigmentosa. Am J Ophthalmol 194:120-125
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Shang, Enyuan; Zhang, Yiru; Shu, Chang et al. (2018) Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems. Sci Rep 8:15383
Shen, Megan Johnson; Prigerson, Holly G; Ratshikana-Moloko, Mpho et al. (2018) Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. J Glob Oncol :1-9
Apatoff, Mary Ben L; Sengillo, Jesse D; White, Eugenia C et al. (2018) Autologous stem cell therapy for inherited and acquired retinal disease. Regen Med 13:89-96
Billing, David; Horiguchi, Michiko; Wu-Baer, Foon et al. (2018) The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection. Mol Cell 72:127-139.e8
Connors, Thomas J; Baird, J Scott; Yopes, Margot C et al. (2018) Developmental Regulation of Effector and Resident Memory T Cell Generation during Pediatric Viral Respiratory Tract Infection. J Immunol 201:432-439

Showing the most recent 10 out of 331 publications